Life Sciences


Call for pension “super funds” to help UK science and tech start-ups

New pension super funds could limit the flow of UK tech and life sciences start-ups choosing to go overseas for listing and investment


BGF raises £80m in extra funds through Coutts

Clients of NatWest private bank Coutts back UK Enterprise Fund with £80m to invest alongside main £3bn BGF fund


UK seeing exodus of R&D activity

Blow to Government ‘science superpower’ dream as 70% of firms plan to move research & development abroad this year


Government proposes to revamp R&D tax credits for small businesses

A consultation document from the Government published on Friday acknowledged there was “merit to the case for further support” to small and medium-sized businesses


A guide to the Silicon Fen tech sector

Cambridge-based companies are generating revenues of £46.6bn, with the city now home to over 5,000 tech companies specialising in biotech, AI and fintech.


University of Oxford spinout investor raises £250m

The £250m funding will see Oxford Science Enterprises overtake Cambridge Innovation Capital as the biggest single investor in UK spinouts


Investors have £20bn to invest in much-needed lab spaces

Demand for life sciences real estate is outperforming supply, as industry investment reached £4.5bn in 2021

Venture Capital Funding

Northern Gritstone on track to raising £500m fund for northern universities

Fund has found backing for its first £100m with another £300m in discussion, enabling it to back two dozen northern university spinouts a year

Venture Capital Funding

British Patient Capital targets life sciences and fintech as key investments

Government’s venture capital arm backs 12 funds with £334m of investment in its first year, bringing total commitments to £600m


Cambridge business closes £1 million deal with help from Angel CoFund and London Business Angels

The Angel CoFund has upped its investment activity by backing bioinformatics company Eagle Genomics alongside London Business Angels.


ISDX to AIM move for Venn Life Sciences

Venn Life Sciences has joined the Alternative Investment Market and raised growth funds to support the move.


Kinapse secures funding to go after strategic acquisitions

Venture capital firm Synova Capital has backed Kinapse, a business which provides outsourcing and consultancy services.